MetaCap

Citius Pharmaceuticals Statistics

NASDAQ: CTXRHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.5085+0.0113 (+2.27%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Citius Pharmaceuticals by the numbers

Citius Pharmaceuticals has a market capitalization of $14.0 million based on 27.45M shares outstanding. With trailing EPS of $-1.75, Citius Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 1.6% below its 50-day average and 20.1% below its 200-day average.

Average daily trading volume is 275.44K shares, or about $140,064 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

CTXR valuation vs. peer median

CTXR compared with the median of 8 peer companies
MetricCTXRPeer medianDifference
Market cap$13.96M$13.63M+2%
Avg. volume275.44K259.61K+6%

Peer median across 8 companies: BYSI, ACTU, NCEL, TVRD, CNTX, CELU, BOLT, NEUP.

Valuation

Price and trading

Previous close
0.4972
Open
0.481
Day range
0.4805 – 0.5136
52-week range
0.37 – 1.54
52-week change
-55.39%
Beta
—
Volume
183.70K

Dividends and events

Annual dividend
None
Next earnings date
Dec 22, 2026

Additional statistics

Market Cap
13.96M
Forward Pe
-0.35
Eps
-1.75
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
1.54
Week52 Low
0.37
Avg Volume
275.44K
Shares Outstanding
27.45M
Ma50
0.52
Ma200
0.64
Earnings Date
Dec 22, 2026
Pct From52w High
-66.98%
Pct From52w Low
37.43%

Related